Literature DB >> 24964346

Synthetic compounds from an in house library as inhibitors of falcipain-2 from Plasmodium falciparum.

Jean Borges Bertoldo1, Louise Domeneghini Chiaradia-Delatorre, Alessandra Mascarello, Paulo César Leal, Marlon Norberto Sechini Cordeiro, Ricardo José Nunes, Emir Salas Sarduy, Philip Jon Rosenthal, Hernán Terenzi.   

Abstract

Falcipain-2 (FP-2) is a key cysteine protease from the malaria parasite Plasmodium falciparum. Many previous studies have identified FP-2 inhibitors; however, none has yet met the criteria for an antimalarial drug candidate. In this work, we assayed an in-house library of non-peptidic organic compounds, including (E)-chalcones, (E)-N'-benzylidene-benzohydrazides and alkyl-esters of gallic acid, and assessed the activity toward FP-2 and their mechanisms of inhibition. The (E)-chalcones 48, 54 and 66 showed the lowest IC50 values (8.5 ± 0.8 µM, 9.5 ± 0.2 µM and 4.9 ± 1.3 µM, respectively). The best inhibitor (compound 66) demonstrated non-competitive inhibition, and using mass spectrometry and fluorescence spectroscopy assays, we suggest a potential allosteric site for the interaction of this compound, located between the catalytic site and the hemoglobin binding arm in FP-2. We combined structural biology tools and mass spectrometry to characterize the inhibition mechanisms of novel compounds targeting FP-2.

Entities:  

Keywords:  Chalcones; Plasmodium falciparum; falcipain-2 inhibitors; malaria

Mesh:

Substances:

Year:  2014        PMID: 24964346     DOI: 10.3109/14756366.2014.920839

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  7 in total

1.  In silico identification of noncompetitive inhibitors targeting an uncharacterized allosteric site of falcipain-2.

Authors:  Jorge Enrique Hernández González; Emir Salas-Sarduy; Lilian Hernández Alvarez; Diego Enry Barreto Gomes; Pedro Geraldo Pascutti; Chris Oostenbrink; Vitor B P Leite
Journal:  J Comput Aided Mol Des       Date:  2021-10-07       Impact factor: 3.686

2.  Synthesis, antibiotic modifying activity, ADMET study and molecular docking of chalcone (E)-3-(2,4-dichlorophenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one in strains of Staphylococcus aureus carrying MepA efflux pumps.

Authors:  Janaína Esmeraldo Rocha; Thiago Sampaio de Freitas; Jayze da Cunha Xavier; Raimundo Luiz Silva Pereira; Francisco Nascimento Pereira; Carlos Emídio Sampaio Nogueira; Márcia Machado Marinho; Paulo Nogueira Bandeira; Maria Alyce Albuquerque Fernandes; Emmanuel Silva Marinho; Alexandre Magno Rodrigues Teixeira; Hélcio Silva Dos Santos; Henrique Douglas Melo Coutinho
Journal:  Arch Microbiol       Date:  2021-12-23       Impact factor: 2.552

3.  In silico Guided Drug Repurposing: Discovery of New Competitive and Non-competitive Inhibitors of Falcipain-2.

Authors:  Lucas N Alberca; Sara R Chuguransky; Cora L Álvarez; Alan Talevi; Emir Salas-Sarduy
Journal:  Front Chem       Date:  2019-08-06       Impact factor: 5.221

4.  South African Abietane Diterpenoids and Their Analogs as Potential Antimalarials: Novel Insights from Hybrid Computational Approaches.

Authors:  Thommas Musyoka; Özlem Tastan Bishop
Journal:  Molecules       Date:  2019-11-07       Impact factor: 4.411

5.  Identification of Plasmodium dipeptidyl aminopeptidase allosteric inhibitors by high throughput screening.

Authors:  Mateo I Sanchez; Laura E de Vries; Christine Lehmann; Jeong T Lee; Kenny K Ang; Christopher Wilson; Steven Chen; Michelle R Arkin; Matthew Bogyo; Edgar Deu
Journal:  PLoS One       Date:  2019-12-18       Impact factor: 3.240

6.  Dissecting a novel allosteric mechanism of cruzain: A computer-aided approach.

Authors:  Lilian Hernández Alvarez; Diego Enry Barreto Gomes; Jorge Enrique Hernández González; Pedro Geraldo Pascutti
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

7.  The complex of Plasmodium falciparum falcipain-2 protease with an (E)-chalcone-based inhibitor highlights a novel, small, molecule-binding site.

Authors:  Jonathan M Machin; Anastassia L Kantsadi; Ioannis Vakonakis
Journal:  Malar J       Date:  2019-12-02       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.